Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 18:46 | 11/15/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 6 | S.d | -2,783 | 51.23 | 0 | -54 | 7 | D | |||||||||||||||
11/19/24 18:46 | 11/19/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 6 | M.d | 2,783 | 51.23 | 0 | 54 | 7 | D | |||||||||||||||
11/14/24 16:37 | 11/12/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 10 | M.dm | 7,266 | 57.23 | 0 | 127 | 0 | D | ||||||||||||||||
11/14/24 16:37 | 11/12/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 10 | S.dm | -7,266 | 57.23 | 0 | -127 | -100 | 0 | D | |||||||||||||||
9/6/24 17:48 | 9/5/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Heery Christopher | CA | O | CHIEF ME | 4 | M.d | 2,495 | 40.41 | 0 | 62 | 9 | D | |||||||||||||||
9/6/24 17:48 | 9/5/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Heery Christopher | CA | O | CHIEF ME | 4 | S.d | -2,495 | 40.41 | 0 | -62 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |